Suppr超能文献

血小板免疫受体酪氨酸激活基序(ITAM)信号与血管完整性。

Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.

机构信息

From the McAllister Heart Institute (Y.B., W.B.) and Department of Biochemistry and Biophysics (W.B.), University of North Carolina, Chapel Hill; and Department of Medicine and Division of Cardiology, University of Pennsylvania, Philadelphia (P.R.H., M.L.K.).

出版信息

Circ Res. 2014 Mar 28;114(7):1174-84. doi: 10.1161/CIRCRESAHA.114.301611.

Abstract

Platelets are well-known for their critical role in hemostasis, that is, the prevention of blood loss at sites of mechanical vessel injury. Inappropriate platelet activation and adhesion, however, can lead to thrombotic complications, such as myocardial infarction and stroke. To fulfill its role in hemostasis, the platelet is equipped with various G protein-coupled receptors that mediate the response to soluble agonists such as thrombin, ADP, and thromboxane A2. In addition to G protein-coupled receptors, platelets express 3 glycoproteins that belong to the family of immunoreceptor tyrosine-based activation motif receptors: Fc receptor γ chain, which is noncovalently associated with the glycoprotein VI collagen receptor, C-type lectin 2, the receptor for podoplanin, and Fc receptor γII A, a low-affinity receptor for immune complexes. Although both genetic and chemical approaches have documented a critical role for platelet G protein-coupled receptors in hemostasis, the contribution of immunoreceptor tyrosine-based activation motif receptors to this process is less defined. Studies performed during the past decade, however, have identified new roles for platelet immunoreceptor tyrosine-based activation motif signaling in vascular integrity in utero and at sites of inflammation. The purpose of this review is to summarize recent findings on how platelet immunoreceptor tyrosine-based activation motif signaling controls vascular integrity, both in the presence and absence of mechanical injury.

摘要

血小板以其在止血(即防止机械性血管损伤部位出血)方面的关键作用而闻名。然而,血小板的不当激活和黏附可导致血栓并发症,如心肌梗死和中风。为了在止血中发挥作用,血小板配备了各种 G 蛋白偶联受体,这些受体介导对可溶性激动剂(如凝血酶、ADP 和血栓烷 A2)的反应。除 G 蛋白偶联受体外,血小板还表达 3 种属于免疫受体酪氨酸激活基序受体家族的糖蛋白:Fc 受体γ链,它与糖蛋白 VI 胶原受体非共价结合,C 型凝集素 2,是 podoplanin 的受体,以及 Fc 受体 γIIA,是免疫复合物的低亲和力受体。尽管遗传和化学方法都证明了血小板 G 蛋白偶联受体在止血中的关键作用,但免疫受体酪氨酸激活基序受体在这一过程中的作用尚不明确。然而,过去十年的研究已经确定了血小板免疫受体酪氨酸激活基序信号在子宫内和炎症部位血管完整性中的新作用。本文的目的是总结最近的发现,即血小板免疫受体酪氨酸激活基序信号如何控制血管完整性,包括在存在和不存在机械损伤的情况下。

相似文献

4
Platelet ITAM signaling.血小板 ITAM 信号转导。
Curr Opin Hematol. 2013 Sep;20(5):445-50. doi: 10.1097/MOH.0b013e3283642267.
5
CLP36 is a negative regulator of glycoprotein VI signaling in platelets.CLP36 是血小板糖蛋白 VI 信号的负调节剂。
Circ Res. 2012 Nov 9;111(11):1410-20. doi: 10.1161/CIRCRESAHA.112.264754. Epub 2012 Sep 5.
9
Molecular mechanisms of immunoreceptors in platelets.血小板中免疫受体的分子机制。
Thromb Res. 2019 Apr;176:108-114. doi: 10.1016/j.thromres.2019.01.019. Epub 2019 Feb 10.

引用本文的文献

2
[Research on immunological function of platelet receptor FcγRⅡA].血小板受体FcγRⅡA的免疫功能研究
Zhonghua Xue Ye Xue Za Zhi. 2023 Jul 14;44(7):609-614. doi: 10.3760/cma.j.issn.0253-2727.2023.07.020.
9
Platelet abnormalities in Huntington's disease.亨廷顿病中的血小板异常。
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):272-283. doi: 10.1136/jnnp-2018-318854. Epub 2018 Dec 19.

本文引用的文献

3
Mechanisms of hemolysis-associated platelet activation.溶血相关血小板激活的机制。
J Thromb Haemost. 2013 Dec;11(12):2148-54. doi: 10.1111/jth.12422.
8
New fundamentals in hemostasis.止血的新基础。
Physiol Rev. 2013 Jan;93(1):327-58. doi: 10.1152/physrev.00016.2011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验